Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors.
about
Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-betaAdvancements in stem cells treatment of skeletal muscle wastingNutraceuticals and Their Potential to Treat Duchenne Muscular Dystrophy: Separating the Credible from the ConjectureEosinophils in hereditary and inflammatory myopathies.Gene expression profiling in limb-girdle muscular dystrophy 2AMarkers of degeneration and regeneration in Duchenne muscular dystrophyRegulatory interactions between muscle and the immune system during muscle regenerationInterleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype.The expanding role(s) of eosinophils in health and disease.Problems and solutions in myoblast transfer therapy.Up-regulation of MHC class I expression accompanies but is not required for spontaneous myopathy in dysferlin-deficient SJL/J mice.The immune system in Duchenne muscular dystrophy: Friend or foe.A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx miceMajor basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy.Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy.Wasting mechanisms in muscular dystrophy.Partial least squares based identification of Duchenne muscular dystrophy specific genes.Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention.Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal MusclesTargeting fibrosis in Duchenne muscular dystrophy.Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy.What do mouse models of muscular dystrophy tell us about the DAPC and its components?Immune-mediated pathology in Duchenne muscular dystrophy.Corticosteroid Treatment Impact on Spinal Deformity in Duchenne Muscular Dystrophy.Unveiling transcription factor regulation and differential co-expression genes in Duchenne muscular dystrophy.Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential rFrom innate to adaptive immune response in muscular dystrophies and skeletal muscle regeneration: the role of lymphocytesInflammatory predisposition predicts disease phenotypes in muscular dystrophy.Targeting early PKCθ-dependent T-cell infiltration of dystrophic muscle reduces disease severity in a mouse model of muscular dystrophy.Expression and regulation of CC class chemokines in the dystrophic (mdx) diaphragm.Increased Number of Circulating CD8/CD26 T Cells in the Blood of Duchenne Muscular Dystrophy Patients Is Associated with Augmented Binding of Adenosine Deaminase and Higher Muscular Strength Scores.Muscle regeneration, inflammation, and connective tissue expansion in canine inflammatory myopathy.Skeletal muscle regeneration is modulated by inflammation.Eosinophilic major basic protein and interleukin-5 in eosinophilic myositis.Myoblast Xenotransplantation as a Tool to Evaluate the Appropriateness of Nanoparticular versus Cellular Trackers
P2860
Q24652960-D48A9422-F565-4685-8F81-20A6011F07D9Q26822437-4161AB2F-4282-438D-AB53-1BCADCE48A72Q28072269-0EA9DC36-DE81-4A16-9EFD-C4431F6B5208Q30317451-43E3A8B6-8DAA-41A5-BA58-7B7E29CFF809Q33385149-267368B9-0035-4605-ADFA-FA4615AE0B9BQ33807694-998FED8D-91E1-4A76-B74C-07B6C4F38554Q33841066-0F4C4206-77AC-468C-B3F2-92F17711FC1BQ34505654-FA2E3288-A0EA-464E-8941-B6BFFBF32978Q34641880-E8AE4141-F497-4D4C-89D6-89C043AD8408Q34687663-DEB3CBE4-788C-4BC1-A8A7-B7024D2BC543Q35788717-A20C4482-4D45-476F-8587-2CE701C841F2Q36105761-544C5EC9-5AF2-4DE2-B0C6-11496F4A6F7DQ36294012-F1878858-945C-4E68-AAFD-55B5952191EEQ36952488-AB49B54B-FC18-4FD3-B3DA-30A2855F2950Q36957496-20A59F73-4BFF-47C6-801F-9F19EF8D1FDEQ37138490-3C5AA675-2B38-4308-B7ED-0B67962BBD07Q37312927-333DB541-0A2D-4B89-BA69-2EE3FCF250CCQ37583167-71A71F3D-0277-475F-B185-491BDB166DEDQ37589790-58E6FA15-F886-408B-A421-1D66F8A0F7C5Q37770947-249AED56-553A-438C-B781-EBFDCC58B818Q38056065-42D9581E-B520-4A42-B5F0-3D9F3103C49DQ38255744-BEC8B4C4-61FA-4319-9E02-7DC8DC02FAFCQ38561435-89DDE4DD-B62E-4BAF-A609-78796B2DEC9EQ38887550-A496A0F8-8F64-4F65-9BE3-CDE904088E9BQ39109298-BD990480-6FF5-4214-9E83-51DA6FC3B478Q42058317-F9EB6651-8022-4FF0-BF6F-4E54E24DB248Q42071747-2324EEE8-1F8A-4B73-A202-A8F75090595FQ47153445-3D15B104-C388-4D7C-B994-5AC402346F77Q47320981-6211436A-A330-4593-8854-4F8D389A42CDQ47806024-7C4F1F9D-D857-4C03-A540-F97105AC2E84Q49220622-451DCB91-43EB-44C7-8465-C1F1C1BCCF9DQ52056444-C8CBB115-8EB4-4F6F-88AA-18562D63970BQ52319498-72F62A01-448A-4255-A7E5-263CE5A7A168Q54794599-471CD32F-C311-4987-86FB-25F1FBBDD71FQ58108738-B0C04AC6-D93C-4B45-848B-8BEA6ACD4FB2
P2860
Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Eosinophilia of dystrophin-def ...... otoxicity by T cell effectors.
@ast
Eosinophilia of dystrophin-def ...... otoxicity by T cell effectors.
@en
type
label
Eosinophilia of dystrophin-def ...... otoxicity by T cell effectors.
@ast
Eosinophilia of dystrophin-def ...... otoxicity by T cell effectors.
@en
prefLabel
Eosinophilia of dystrophin-def ...... otoxicity by T cell effectors.
@ast
Eosinophilia of dystrophin-def ...... otoxicity by T cell effectors.
@en
P2093
P2860
P1476
Eosinophilia of dystrophin-def ...... otoxicity by T cell effectors.
@en
P2093
P2860
P304
P356
10.1016/S0002-9440(10)65050-X
P407
P577
2000-05-01T00:00:00Z